Difference between revisions of "Test"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Line 194: | Line 194: | ||
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | ||
+ | |||
+ | |||
+ | |||
+ | == Mature T- and NK-cell Neoplasms == | ||
+ | *[[T-cell Prolymphocytic Leukemia]] | ||
+ | |||
+ | *[[T-cell Large Granular Lymphocytic Leukemia]] | ||
+ | |||
+ | *[[Chronic Lymphoproliferative Disorder of NK Cells]] | ||
+ | |||
+ | *[[Aggressive NK-cell Leukemia]] | ||
+ | |||
+ | *[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]] | ||
+ | - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]] | ||
+ | - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]] | ||
+ | - [[Hydroa Vacciniforme-Like Lymphoproliferative Disorder]] | ||
+ | - [[Severe Mosquito Bite Allergy]] | ||
+ | |||
+ | *[[Adult T-cell Leukemia/Lymphoma]] | ||
+ | |||
+ | *[[Extranodal NK/T-cell Lymphoma, Nasal Type]] | ||
+ | |||
+ | *[[Intestinal T-cell Lymphoma]] | ||
+ | - [[Enteropathy-Associated T-cell Lymphoma]] | ||
+ | - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]] | ||
+ | - [[Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
+ | - [[Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]] | ||
+ | |||
+ | *[[Hepatosplenic T-cell Lymphoma]] | ||
+ | |||
+ | *[[Subcutaneous Panniculitis-Like T-cell Lymphoma]] | ||
+ | |||
+ | *[[Mycosis Fungoides]] | ||
+ | |||
+ | *[[Sézary Syndrome]] | ||
+ | |||
+ | *[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] | ||
+ | - [[Lymphomatoid Papulosis]] | ||
+ | - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]] | ||
+ | |||
+ | *[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]] | ||
+ | - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]] | ||
+ | - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]] | ||
+ | - [[Primary Cutaneous Acral CD8+ T-cell Lymphoma]] | ||
+ | - [[Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder]] | ||
+ | |||
+ | *[[Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
+ | |||
+ | *[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]] | ||
+ | - [[Angioimmunoblastic T-cell Lymphoma]] | ||
+ | - [[Follicular T-cell Lymphoma]] | ||
+ | - [[Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]] | ||
+ | |||
+ | *[[Anaplastic Large Cell Lymphoma, ALK-Positive]] | ||
+ | |||
+ | *[[Anaplastic Large Cell Lymphoma, ALK-Negative]] | ||
+ | |||
+ | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | ||
<comments /> | <comments /> |
Revision as of 17:12, 20 February 2021
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- AML with Recurrent Genetic Abnormalities
- AML with Myelodysplasia-Related Changes
- sub division
- sub-sub-sub division
- sub division
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - Acute Promyelocytic Leukemia (APL) with PML-RARA - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 - AML with t(6;9)(p23;q34.1); DEK-NUP214 - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 - AML with BCR-ABL1 - AML with Mutated NPM1 - AML with Biallelic Mutations of CEBPA - AML with Mutated RUNX1
- AML with Minimal Differentiation - AML without Maturation - AML with Maturation - Acute Myelomonocytic Leukemia - Acute Monoblastic and Monocytic Leukemia - Pure Erythroid Leukemia - Acute Megakaryoblastic Leukemia (AMKL) - Acute Basophilic Leukemia - Acute Panmyelosis with Myelofibrosis
- Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome - Myeloid Leukemia Associated with Down Syndrome
- Acute Undifferentiated Leukemia - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)
- Acute Myeloid Leukaemia with Germline CEBPA Mutation - Myeloid Neoplasms with Germline DDX41 Mutation - Myeloid Neoplasms with Germline RUNX1 Mutation - Myeloid Neoplasms with Germline ANKRD26 Mutation - Myeloid Neoplasms with Germline ETV6 Mutation - Myeloid Neoplasms with Germline GATA2 Mutation
Myelodysplastic Syndromes (MDS)
- MDS with Single Lineage Dysplasia
- MDS with Ring Sideroblasts (MDS-RS)
- MDS with Ring Sideroblasts and Multilineage Dysplasia
- MDS with Multilineage Dysplasia
- MDS with Excess Blasts
- MSD with Isolated del(5q)
- MDS, Unclassifiable
- Refractory Cytopenia of Childhood
Myeloproliferative Neoplasms (MPN)
- Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
- Chronic Neutrophilic Leukemia (CNL)
- Polycythemia Vera (PV)
- Primary Myelofibrosis (PMF)
- Essential Thrombocythemia (ET)
- Chronic Eosinophilic Leukemia, Not Otherwise Specified
- Myeloproliferative Neoplasm (MPN), Unclassifiable
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
- Chronic Myelomonocytic Leukemia (CMML)
- Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative
- Juvenile Myelomonocytic Leukemia (JMML)
- MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
- MDS/MPN, Unclassifiable
Mature B-Cell Neoplasms
- Monoclonal B-cell Lymphocytosis
- Splenic Diffuse Red Pulp Small B-cell Lymphoma - Hairy Cell Leukemia Variant
- Waldenstrom Macroglobulinemia
- Mu Heavy Chain Disease - Gamma Heavy Chain Disease - Alpha Heavy Chain Disease
- Non-IgM Monoclonal Gammopathy of Undetermined Significance - Plasma Cell Myeloma - Plasma Cell Myeloma Variants - Plasmacytoma - Monoclonal Immunoglobulin Deposition Diseases - Primary Amyloidosis - Light Chain and Heavy Chain Deposition Disease - Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome - POEMS Syndrome - TEMPI Syndrome
- Paediatric Nodal Marginal Zone Lymphoma
- Testicular Follicular Lymphoma - In Situ Follicular Neoplasia - Duodenal-Type Follicular Lymphoma
- Leukemic Non-Nodal Mantle Cell Lymphoma - In Situ Mantle Cell Neoplasia
- Fibrin-Associated Diffuse Large B-cell Lymphoma
- Multicentric Castleman Disease - HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) - HHV8-Positive Germinotropic Lymphoproliferative Disorder
- High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements - High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)
Mature T- and NK-cell Neoplasms
- Systemic EBV-Positive T-cell Lymphoma of Childhood - Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form - Hydroa Vacciniforme-Like Lymphoproliferative Disorder - Severe Mosquito Bite Allergy
- Enteropathy-Associated T-cell Lymphoma - Monomorphic Epitheliotropic Intestinal T-cell Lymphoma - Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) - Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
- Lymphomatoid Papulosis - Primary Cutaneous Anaplastic Large Cell Lymphoma
- Primary Cutaneous Gamma Delta T-cell Lymphoma - Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma - Primary Cutaneous Acral CD8+ T-cell Lymphoma - Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder
- Angioimmunoblastic T-cell Lymphoma - Follicular T-cell Lymphoma - Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype
Enable comment auto-refresher
Dan
Permalink |
Dan